214 related articles for article (PubMed ID: 17621369)
1. TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function.
Jiang W; Lederman MM; Harding CV; Rodriguez B; Mohner RJ; Sieg SF
Eur J Immunol; 2007 Aug; 37(8):2205-13. PubMed ID: 17621369
[TBL] [Abstract][Full Text] [Related]
2. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
Giordani L; Sanchez M; Libri I; Quaranta MG; Mattioli B; Viora M
J Leukoc Biol; 2009 Aug; 86(2):261-71. PubMed ID: 19401392
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor stimulation as a third signal required for activation of human naive B cells.
Ruprecht CR; Lanzavecchia A
Eur J Immunol; 2006 Apr; 36(4):810-6. PubMed ID: 16541472
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of TLR9 responses for human naïve B-cell growth through RP105 signaling.
Yamazaki K; Yamazaki T; Taki S; Miyake K; Hayashi T; Ochs HD; Agematsu K
Clin Immunol; 2010 Apr; 135(1):125-36. PubMed ID: 20133206
[TBL] [Abstract][Full Text] [Related]
5. Human B cell responses to TLR ligands are differentially modulated by myeloid and plasmacytoid dendritic cells.
Douagi I; Gujer C; Sundling C; Adams WC; Smed-Sörensen A; Seder RA; Karlsson Hedestam GB; Loré K
J Immunol; 2009 Feb; 182(4):1991-2001. PubMed ID: 19201852
[TBL] [Abstract][Full Text] [Related]
6. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
[TBL] [Abstract][Full Text] [Related]
7. Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation.
Dil N; Marshall AJ
Mol Immunol; 2009 Jun; 46(10):1970-8. PubMed ID: 19362372
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production.
Glaum MC; Narula S; Song D; Zheng Y; Anderson AL; Pletcher CH; Levinson AI
J Allergy Clin Immunol; 2009 Jan; 123(1):224-230.e4. PubMed ID: 18995892
[TBL] [Abstract][Full Text] [Related]
9. Effect of synthetic agonists of toll-like receptor 9 on canine lymphocyte proliferation and cytokine production in vitro.
Im Hof M; Williamson L; Summerfield A; Balmer V; Dutoit V; Kandimalla ER; Yu D; Zurbriggen A; Doherr MG; Peel J; Roosje PJ
Vet Immunol Immunopathol; 2008 Jul; 124(1-2):120-31. PubMed ID: 18452997
[TBL] [Abstract][Full Text] [Related]
10. Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.
Katsenelson N; Kanswal S; Puig M; Mostowski H; Verthelyi D; Akkoyunlu M
Eur J Immunol; 2007 Jul; 37(7):1785-95. PubMed ID: 17557373
[TBL] [Abstract][Full Text] [Related]
11. B-cell receptor for antigen modulates B-cell responses to complex TLR9 agonists and antagonists: implications for systemic lupus erythematosus.
Goeken JA; Layer T; Fleenor S; Laccheo M; Lenert P
Lupus; 2010 Oct; 19(11):1290-301. PubMed ID: 20605877
[TBL] [Abstract][Full Text] [Related]
12. The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of Toll-like receptor 9 and activation by CpG oligonucleotides.
Henault M; Lee LN; Evans GF; Zuckerman SH
J Immunol Methods; 2005 May; 300(1-2):93-9. PubMed ID: 15894327
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients.
Traggiai E; Volpi S; Schena F; Gattorno M; Ferlito F; Moretta L; Martini A
Stem Cells; 2008 Feb; 26(2):562-9. PubMed ID: 18024418
[TBL] [Abstract][Full Text] [Related]
14. Role of marginal zone B lymphocytes in invariant NKT cell activation.
Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
[TBL] [Abstract][Full Text] [Related]
15. Superantigen- and TLR-dependent activation of tonsillar B cells after receptor-mediated endocytosis.
Jendholm J; Mörgelin M; Perez Vidakovics ML; Carlsson M; Leffler H; Cardell LO; Riesbeck K
J Immunol; 2009 Apr; 182(8):4713-20. PubMed ID: 19342647
[TBL] [Abstract][Full Text] [Related]
16. Effects of NOD-like receptors in human B lymphocytes and crosstalk between NOD1/NOD2 and Toll-like receptors.
Petterson T; Jendholm J; Månsson A; Bjartell A; Riesbeck K; Cardell LO
J Leukoc Biol; 2011 Feb; 89(2):177-87. PubMed ID: 20844241
[TBL] [Abstract][Full Text] [Related]
17. Functional TLR9 modulates bone marrow B cells from rheumatoid arthritis patients.
Rudnicka W; Burakowski T; Warnawin E; Jastrzebska M; Bik M; Kontny E; Chorazy-Massalska M; Radzikowska A; Buler M; Maldyk P; Maslinski W
Eur J Immunol; 2009 May; 39(5):1211-20. PubMed ID: 19384869
[TBL] [Abstract][Full Text] [Related]
18. Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease.
Wang D; John SA; Clements JL; Percy DH; Barton KP; Garrett-Sinha LA
Int Immunol; 2005 Sep; 17(9):1179-91. PubMed ID: 16051621
[TBL] [Abstract][Full Text] [Related]
19. Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation.
Carpenter EL; Mick R; Rüter J; Vonderheide RH
J Transl Med; 2009 Nov; 7():93. PubMed ID: 19906293
[TBL] [Abstract][Full Text] [Related]
20. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells.
Zheng J; Liu Y; Qin G; Chan PL; Mao H; Lam KT; Lewis DB; Lau YL; Tu W
J Immunol; 2009 Sep; 183(6):3742-50. PubMed ID: 19684082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
